Evidence map›Paper›PMID 42773264›Full record

ReviewChirurgie (Heidelberg, Germany)2026

[Surgical treatment of primary malignant bone tumors : Local therapeutic considerations with respect to extent of resection and reconstruction in a multimodal treatment concept].

Arne Streitbürger, Jendrik Hardes, Nina Myline Engel

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Chirurgie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Arne StreitbürgerKlinik für Tumororthopädie und Sarkomchirurgie, Universitätsklinikum Essen, Hufelandstr. 55, 45147, Essen, Deutschland. arne.streitbuerger@uk-essen.de.
Jendrik HardesKlinik für Tumororthopädie und Sarkomchirurgie, Universitätsklinikum Essen, Hufelandstr. 55, 45147, Essen, Deutschland.
Nina Myline EngelKlinik für Tumororthopädie und Sarkomchirurgie, Universitätsklinikum Essen, Hufelandstr. 55, 45147, Essen, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The modern treatment of primary bone sarcomas is integrated into a multimodal treatment concept consisting of systemic and local therapeutic modalities. Conventional chemotherapy plays the leading role in first line treatment. In terms of local treatment of the primary tumor, complete tumor removal (R0 resection) is the procedure of choice in a curative treatment concept. In Ewing's sarcoma, additive local radiotherapy must be taken into account in the surgical planning as well as the choice of reconstruction procedure. In a palliative treatment approach, an individual treatment adaptation must be made. Depending on the tumor site and individual parameters, different reconstruction procedures are available. The quality of tumor removal directly influences the local recurrence rate, overall prognosis and type of reconstruction. Due to the rarity of the disease and the necessary high degree of specialization of the disciplines involved, treatment of bone sarcomas is restricted to specialized centers.

Indexed as

Bone sarcomaReconstruction proceduresResection marginSarcoma centersSurgical local treatment

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.